NASDAQ, TSX: NVCN
VANCOUVER, Nov. 7, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or
the "Company") (NASDAQ, TSX: NVCN), a leader in the development of
minimally invasive transcatheter mitral valve replacement
technologies and in the development of minimally invasive devices
for the treatment of refractory angina, today announced that it
will report financial results for the quarter and nine months ended
September 30, 2018 and host a
conference call and webcast at 4:30pm
Eastern Time on Wednesday, November 14, 2018.
Conference Call & Webcast
Wednesday,
November 14th @ 4:30pm Eastern Time
|
Domestic:
|
855-283-1097
|
International:
|
323-794-2575
|
Passcode:
|
7885315
|
Webcast:
|
http://public.viavid.com/index.php?id=131832
|
|
|
Replays available
through November 28th:
|
Domestic:
|
844-512-2921
|
International:
|
412-317-6671
|
Conference
ID:
|
7885315
|
About Neovasc Inc.
Neovasc is a specialty medical
device company that develops, manufactures and markets products for
the rapidly growing cardiovascular marketplace. Its products
include the Neovasc Reducer™ (the "Reducer"), for the treatment of
refractory angina, which is not currently commercially available in
the United States and has been
commercially available in Europe
since 2015, and the Tiara™ (the "Tiara"), for the transcatheter
treatment of mitral valve disease, which is currently under
clinical investigation in the United
States , Canada and
Europe . For more information,
visit: www.neovasc.com.
View original
content:http://www.prnewswire.com/news-releases/neovasc-announces-third-quarter-2018-financial-results-conference-call-and-webcast-300745342.html
SOURCE Neovasc Inc.